Leerink Partners Remains Bullish on Alnylam Pharma (ALNY) Ahead of ALN-PCSsc Ph I data

Go back to Leerink Partners Remains Bullish on Alnylam Pharma (ALNY) Ahead of ALN-PCSsc Ph I data
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 252.56 +8.24 (3.37%)
Previous Close $244.32    52 Week High $109.10 
Open $246.86    52 Week Low $31.38 
Day High $255.51    P/E N/A 
Day Low $244.13    EPS $-1.45 
Volume 467,593